Zoetis Inc. (0M3Q.L)

USD 169.5

(-0.56%)

Eps Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual eps in 2023 was 5.08 USD , up 12.64% from previous year.
  • Zoetis Inc.'s latest quarterly eps in 2024 Q3 was 1.51 USD , up 10.22% from previous quarter.
  • Zoetis Inc. reported an annual eps of 4.51 USD in 2022, up 5.13% from previous year.
  • Zoetis Inc. reported an annual eps of 4.29 USD in 2021, up 24.71% from previous year.
  • Zoetis Inc. reported a quarterly eps of 1.31 USD for 2024 Q1, up 14.91% from previous quarter.
  • Zoetis Inc. reported a quarterly eps of 1.51 USD for 2024 Q3, up 10.22% from previous quarter.

Annual Eps Chart of Zoetis Inc. (2023 - 2009)

Historical Annual Eps of Zoetis Inc. (2023 - 2009)

Year Eps Eps Growth
2023 5.08 USD 12.64%
2022 4.51 USD 5.13%
2021 4.29 USD 24.71%
2020 3.44 USD 9.55%
2019 3.14 USD 6.08%
2018 2.96 USD 68.18%
2017 1.76 USD 6.02%
2016 1.66 USD 144.12%
2015 0.68 USD -41.38%
2014 1.16 USD 14.85%
2013 1.01 USD 16.09%
2012 0.87 USD 70.59%
2011 0.51 USD 121.74%
2010 0.23 USD 209.52%
2009 -0.21 USD 0.0%

Peer Eps Comparison of Zoetis Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 351.485%
Dynavax Technologies Corporation -0.05 USD 10341.935%
Supernus Pharmaceuticals, Inc. 0.02 USD -20978.838%
Perrigo Company plc -0.09 USD 5510.011%
Illumina, Inc. -7.35 USD 169.116%
Thermo Fisher Scientific Inc. 15.53 USD 67.289%
Iovance Biotherapeutics, Inc. -1.89 USD 368.783%
Walgreens Boots Alliance, Inc. -10.01 USD 150.749%
IQVIA Holdings Inc. 7.39 USD 31.258%
Heron Therapeutics, Inc. -0.80 USD 735.0%
Regeneron Pharmaceuticals, Inc. 37.05 USD 86.289%
Unity Biotechnology, Inc. -2.70 USD 288.148%
Waters Corporation 10.87 USD 53.266%
Biogen Inc. 8.02 USD 36.658%
Sangamo Therapeutics, Inc. -1.48 USD 443.243%
Evolus, Inc. -1.08 USD 570.37%
Adicet Bio, Inc. -3.31 USD 253.474%
Cara Therapeutics, Inc. -2.19 USD 331.963%
bluebird bio, Inc. -1.93 USD 363.212%
Esperion Therapeutics, Inc. -2.03 USD 350.246%
FibroGen, Inc. -2.92 USD 273.973%
Agilent Technologies, Inc. 4.22 USD -20.379%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 149.273%
Homology Medicines, Inc. -7.41 USD 168.556%
Geron Corporation -0.32 USD 1687.5%
Alnylam Pharmaceuticals, Inc. -3.52 USD 244.318%
Amicus Therapeutics, Inc. -0.51 USD 1096.078%
Myriad Genetics, Inc. -1.39 USD 465.468%
Viking Therapeutics, Inc. -0.91 USD 658.242%
Intellia Therapeutics, Inc. -5.42 USD 193.727%
Abeona Therapeutics Inc. -2.53 USD 300.791%
Mettler-Toledo International Inc. 36.10 USD 85.928%
BioMarin Pharmaceutical Inc. 0.89 USD -470.787%
Vertex Pharmaceuticals Incorporated 14.05 USD 63.843%
Kala Pharmaceuticals, Inc. -17.35 USD 129.28%
Ionis Pharmaceuticals, Inc. -2.56 USD 298.438%
Atara Biotherapeutics, Inc. -65.18 USD 107.794%
Verastem, Inc. -3.96 USD 228.283%
Nektar Therapeutics -1.45 USD 450.345%
Axsome Therapeutics, Inc. -5.27 USD 196.395%
Aclaris Therapeutics, Inc. -1.27 USD 500.0%
Sarepta Therapeutics, Inc. -5.80 USD 187.586%
OPKO Health, Inc. -0.25 USD 2132.0%
Exelixis, Inc. 0.65 USD -681.538%
Neurocrine Biosciences, Inc. 2.56 USD -98.438%
Corcept Therapeutics Incorporated 1.02 USD -398.039%
Anavex Life Sciences Corp. -0.60 USD 946.667%
uniQure N.V. -6.47 USD 178.516%
Imunon, Inc. -2.16 USD 335.185%
Blueprint Medicines Corporation -8.37 USD 160.693%
Insmed Incorporated -5.34 USD 195.131%
Halozyme Therapeutics, Inc. 2.13 USD -138.498%
Agios Pharmaceuticals, Inc. -6.33 USD 180.253%
TG Therapeutics, Inc. 0.09 USD -5588.69%
Incyte Corporation 2.67 USD -90.262%
Emergent BioSolutions Inc. -14.85 USD 134.209%